Please Wait.....
Report
Clinical Trial Supplies - Company Evaluation Report, 2025
Market Report I 2025-08-01 I 108 Pages I MarketsandMarkets
The Clinical Trial Supplies Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Clinical Trial Supplies. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 120 companies, of which the Top 17 Clinical Trial Supplies Companies were categorized and recognized as the quadrant leaders.
The clinical trial supplies market is experiencing significant growth, driven by the increasing complexity of clinical trials, the rise in biologics and personalized medicine, and the globalization of clinical research. To manage costs, ensure regulatory compliance, and improve logistical efficiency, pharmaceutical and biotechnology companies are increasingly outsourcing supply chain operations to specialized service providers. Key innovations such as temperature-controlled packaging, direct-to-patient (DTP) delivery models, and the rise of decentralized clinical trials are accelerating demand for advanced supply chain solutions. The growing adoption of biologics, as well as cell and gene therapies, has further increased the need for robust cold chain logistics, real-time temperature monitoring, and cryogenic storage capabilities.
Digital transformation is also reshaping clinical trial supply management. AI-powered demand forecasting, blockchain-enabled transparency, and cloud-based inventory systems are enhancing operational efficiency and data integrity. As a result, pharmaceutical and biotech firms are partnering more frequently with Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) to access integrated, end-to-end clinical trial supply solutions-further fueling market expansion.
The 360 Quadrant maps the Clinical Trial Supplies companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Clinical Trial Supplies quadrant. The top criteria for product footprint evaluation included Service (logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing and other services) phase (Phase III, Phase II, Phase I, Phase IV, and Phase BA/BE) type (small molecules, biologics, and medical devices) therapeutic area (oncology, neurology, respiratory disorders, metabolic disorders/endocrinology, cardiovascular system disorders, dermatology, gastrointestinal system disorders, immunological disorders, infectious diseases, psychiatry, ophthalmology, hematology, genitourinary & women's health, and other therapeutic areas).
Key Players:
Some of the prominent players are Thermo Fisher Scientific Inc. (US), Novo Holdings A/S (Denmark), Marken (UPS) (US), Eurofins Scientific (Luxembourg), Piramal Group (India), Almac Group (UK), Novo Holdings A/S (Denmark), Marken (UPS) (US), PCI Pharma Services (US), and Sharp Services LLC (US), and others. These players are increasingly focusing on product launches and enhancements, investments, partnerships, collaborations, joint ventures, funding, acquisitions, expansions, agreements, sales contracts, and alliances to strengthen their presence in the global market.
Top 3 Companies
Thermo Fisher Scientific
Thermo Fisher Scientific is a global leader in science and technology, specializing in high-end analytical instruments, laboratory equipment, consumables, reagents, software, and services that support scientific research, discovery, diagnostics, and analysis. The company operates through four primary business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Biopharma Services. Thermo Fisher's presence in the clinical trial supplies market is anchored through its subsidiary PPD, which falls under the Laboratory Products & Biopharma Services segment. The company delivers a wide range of solutions through its prominent brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
Sharp Services LLC
Sharp Services is a global provider of contract packaging and clinical trial supply solutions, serving the pharmaceutical, biotechnology, and life sciences industries. The company delivers end-to-end clinical trial services including GMP-compliant primary and secondary packaging, multi-language labeling, blinding services, cold chain logistics, Just-in-Time (JIT) labeling, and global storage and distribution. Sharp supports both clinical and commercial needs while ensuring regulatory compliance and operational flexibility. Headquartered in the United States, Sharp maintains GMP-certified facilities in the U.S. and the U.K., with operations extending across North America and Europe. Its key subsidiaries include Sharp Laboratories of America, Inc. (SLA), Sharp Hong Kong Limited (SHK), Sharp Manufacturing (Thailand) Co., Ltd. (SMTL), and Sharp Corporation of Australia Pty. Ltd. (SCA).
Parexel International
Parexel International is a leading contract research organization (CRO) that offers comprehensive drug development and regulatory services to pharmaceutical, biotech, and medical device companies. Its core business segment, Clinical Research Services (CRS), encompasses full-spectrum clinical trial management from Phase I to Phase IV, along with biostatistics, pharmacovigilance, data management, regulatory affairs, market access consulting, observational studies, and clinical logistics. Headquartered in the U.S., Parexel has a strong international footprint, with 85 offices across 52 countries. Notable subsidiaries include Parexel International S.A. (Argentina), Parexel Belgium SPRL, Parexel International, LLC (U.S.), Parexel International (Canada) Ltd., Parexel China Ding Hui Co., Ltd., Parexel International GmbH (Germany), Parexel International Limited (UK), and Parexel International Inc. (Japan).
1 INTRODUCTION 11
1.1 MARKET DEFINITION 11
1.2 INCLUSIONS & EXCLUSIONS 11
1.3 STAKEHOLDERS 11
2 EXECUTIVE SUMMARY 12
3 MARKET OVERVIEW 17
3.1 INTRODUCTION 17
3.2 MARKET DYNAMICS 18
3.2.1 DRIVERS 18
3.2.1.1 Growth in clinical trials & drug development 18
3.2.1.2 Expansion of global and multicenter trials accelerating demand for clinical trial supplies 19
3.2.1.3 Rising demand for personalized medicine and biologics 20
3.2.2 RESTRAINTS 20
3.2.2.1 High costs associated with clinical trial supplies 20
3.2.3 OPPORTUNITIES 21
3.2.3.1 Rise in decentralized and virtual trials 21
3.2.3.2 Integration of digital technologies in supply chain management 21
3.2.4 CHALLENGES 21
3.2.4.1 Supply chain disruptions and drug shortages 21
3.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 22
3.4 VALUE CHAIN ANALYSIS 23
3.5 ECOSYSTEM ANALYSIS 25
3.5.1 CLINICAL TRIAL SUPPLIES MARKET: RAW MATERIAL PROVIDERS 26
3.5.2 CLINICAL TRIAL SUPPLIES MARKET: SERVICE PROVIDERS 26
3.5.3 CLINICAL TRIAL SUPPLIES MARKET: END USERS 27
3.5.4 CLINICAL TRIAL SUPPLIES MARKET: REGULATORY BODIES 27
3.6 TECHNOLOGY ANALYSIS 28
3.6.1 KEY TECHNOLOGIES 28
3.6.1.1 Serialization & track-and-trace technologies 28
3.6.1.2 Interactive response technology (IRT/IVR/IWR) 28
3.6.1.3 Cold chain & temperature monitoring solutions 28
3.6.2 COMPLEMENTARY TECHNOLOGIES 28
3.6.2.1 Artificial intelligence (AI) & machine learning (ML) 28
3.6.2.2 Blockchain for supply chain transparency 29
?
3.6.3 ADJACENT TECHNOLOGIES 29
3.6.3.1 Cryopreservation & advanced storage technologies 29
3.6.3.2 Advanced robotics in warehousing & distribution 29
3.7 KEY CONFERENCES AND EVENTS, 2025-2026 29
3.8 PORTER'S FIVE FORCES ANALYSIS 30
3.8.1 THREAT OF NEW ENTRANTS 31
3.8.2 BARGAINING POWER OF SUPPLIERS 31
3.8.3 BARGAINING POWER OF BUYERS 32
3.8.4 THREAT OF SUBSTITUTES 32
3.8.5 INTENSITY OF COMPETITIVE RIVALRY 32
3.9 IMPACT OF AI/GENERATIVE AI ON CLINICAL TRIAL SUPPLIES MARKET 32
3.9.1 INTRODUCTION 32
3.9.2 FUTURE OF GENERATIVE AI IN CLINICAL TRIAL SUPPLIES ECOSYSTEM 34
4 COMPETITIVE LANDSCAPE 35
4.1 INTRODUCTION 35
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 35
4.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLINICAL TRIAL SUPPLIES MARKET 35
4.3 REVENUE ANALYSIS, 2020-2024 36
4.4 MARKET SHARE ANALYSIS, 2024 37
4.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 40
4.5.1 STARS 40
4.5.2 EMERGING LEADERS 40
4.5.3 PERVASIVE PLAYERS 40
4.5.4 PARTICIPANTS 40
4.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 42
4.5.5.1 Company footprint 42
4.5.5.2 Region footprint 42
4.5.5.3 Service footprint 43
4.5.5.4 Type footprint 44
4.5.5.5 End-user footprint 45
4.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 45
4.6.1 PROGRESSIVE COMPANIES 45
4.6.2 RESPONSIVE COMPANIES 45
4.6.3 DYNAMIC COMPANIES 46
4.6.4 STARTING BLOCKS 46
4.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 47
4.6.5.1 Detailed list of key startups/SMEs 47
4.6.5.2 Competitive benchmarking of key startups/SMEs 48
?
4.7 COMPANY VALUATION & FINANCIAL METRICS 49
4.7.1 COMPANY VALUATION 49
4.7.2 FINANCIAL METRICS 49
4.8 BRAND/SERVICE COMPARISON 50
4.9 COMPETITIVE SCENARIO 51
4.9.1 DEALS 51
4.9.2 EXPANSIONS 51
5 COMPANY PROFILES 53
5.1 KEY PLAYERS 53
5.1.1 THERMO FISHER SCIENTIFIC INC. 53
5.1.1.1 Business overview 53
5.1.1.2 Services offered 54
5.1.1.3 Recent developments 55
5.1.1.3.1 Service launches 55
5.1.1.3.2 Deals 55
5.1.1.3.3 Expansions 56
5.1.1.4 MnM view 56
5.1.1.4.1 Right to win 56
5.1.1.4.2 Strategic choices 56
5.1.1.4.3 Weaknesses & competitive threats 56
5.1.2 NOVO HOLDINGS A/S 57
5.1.2.1 Business overview 57
5.1.2.2 Services offered 58
5.1.2.3 Recent developments 59
5.1.2.3.1 Deals 59
5.1.2.3.2 Expansions 60
5.1.2.4 MnM view 60
5.1.2.4.1 Right to win 60
5.1.2.4.2 Strategic choices 60
5.1.2.4.3 Weaknesses & competitive threats 60
5.1.3 UNITED PARCEL SERVICE OF AMERICA, INC. 61
5.1.3.1 Business overview 61
5.1.3.2 Services offered 61
5.1.3.3 MnM view 62
5.1.3.3.1 Right to win 62
5.1.3.3.2 Strategic choices 62
5.1.3.3.3 Weaknesses & competitive threats 63
5.1.4 EUROFINS SCIENTIFIC 64
5.1.4.1 Business overview 64
5.1.4.2 Services offered 65
5.1.4.3 MnM view 66
5.1.4.3.1 Right to win 66
5.1.4.3.2 Strategic choices 66
5.1.4.3.3 Weaknesses & competitive threats 66
5.1.5 PIRAMAL PHARMA LIMITED 67
5.1.5.1 Business overview 67
5.1.5.2 Services offered 68
5.1.5.3 MnM view 69
5.1.5.3.1 Right to win 69
5.1.5.3.2 Strategic choices 69
5.1.5.3.3 Weaknesses & competitive threats 69
5.1.6 IQVIA 70
5.1.6.1 Business overview 70
5.1.6.2 Services offered 72
5.1.7 ICON PLC 73
5.1.7.1 Business overview 73
5.1.7.2 Services offered 74
5.1.7.3 Recent developments 75
5.1.7.3.1 Deals 75
5.1.8 LONZA 76
5.1.8.1 Business overview 76
5.1.8.2 Services offered 77
5.1.8.3 Recent developments 77
5.1.8.3.1 Deals 77
5.1.9 UNIPHAR GROUP PLC 78
5.1.9.1 Business overview 78
5.1.9.2 Services offered 79
5.1.10 ALMAC GROUP 80
5.1.10.1 Business overview 80
5.1.10.2 Services offered 80
5.1.10.3 Recent developments 81
5.1.10.3.1 Expansions 81
5.1.11 SHARP SERVICES, LLC 82
5.1.11.1 Business overview 82
5.1.11.2 Services offered 82
5.1.12 PCI PHARMA SERVICES 84
5.1.12.1 Business overview 84
5.1.12.2 Services offered 84
5.1.12.3 Recent developments 85
5.1.12.3.1 Expansions 85
?
5.1.13 PAREXEL INTERNATIONAL (MA) CORPORATION 86
5.1.13.1 Business overview 86
5.1.13.2 Services offered 86
5.1.13.3 Recent developments 87
5.1.13.3.1 Deals 87
5.1.14 BIOCAIR 88
5.1.14.1 Business overview 88
5.1.14.2 Services offered 88
5.2 OTHER PLAYERS 89
5.2.1 CENCORA, INC. 89
5.2.2 CLINIGEN LIMITED 90
5.2.3 KLIFO 91
5.2.4 IPS PHARMA 92
5.2.5 COREX LOGISTICS LIMITED 93
5.2.6 OCT GROUP LLC 94
5.2.7 MYONEX 95
5.2.8 INCEPTUA GROUP 96
5.2.9 ANCILLARE, LP 97
5.2.10 ADALLEN PHARMA 98
5.2.11 CLINICAL SERVICES INTERNATIONAL (CSI) 99
5.2.12 NUVISAN GMBH 100
5.2.13 AENOVA HOLDING GMBH 101
6 APPENDIX 102
6.1 RESEARCH METHODOLOGY 102
6.1.1 RESEARCH DATA 102
6.1.1.1 Secondary data 102
6.1.1.2 Primary research 103
6.1.2 RESEARCH ASSUMPTIONS 103
6.1.3 RESEARCH LIMITATIONS 104
6.1.4 RISK ANALYSIS 105
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY 105
6.3 AUTHOR DETAILS 108
TABLE 1 CLINICAL TRIAL SUPPLIES MARKET: PRODUCT MANUFACTURERS 26
TABLE 2 CLINICAL TRIAL SUPPLIES MARKET: SERVICE PROVIDERS 26
TABLE 3 CLINICAL TRIAL SUPPLIES MARKET: END USERS 27
TABLE 4 CLINICAL TRIAL SUPPLIES MARKET: REGULATORY BODIES 27
TABLE 5 CLINICAL TRIAL SUPPLIES MARKET: KEY CONFERENCES AND EVENTS,
2025-2026 29
TABLE 6 CLINICAL TRIAL SUPPLIES MARKET: PORTER'S FIVE FORCES ANALYSIS 30
TABLE 7 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
CLINICAL TRIAL SUPPLIES MARKET 35
TABLE 8 CLINICAL TRIAL SUPPLIES MARKET: DEGREE OF COMPETITION 38
TABLE 9 CLINICAL TRIALS SUPPLIES MARKET: REGION FOOTPRINT 42
TABLE 10 CLINICAL TRIAL SUPPLIES MARKET: SERVICE FOOTPRINT 43
TABLE 11 CLINICAL TRIAL SUPPLIES MARKET: TYPE FOOTPRINT 44
TABLE 12 CLINICAL TRIAL SUPPLIES MARKET: END-USER FOOTPRINT 45
TABLE 13 CLINICAL TRIAL SUPPLIES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 47
TABLE 14 CLINICAL TRIAL SUPPLIES MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 48
TABLE 15 CLINICAL TRIAL SUPPLIES MARKET: DEALS, JANUARY 2021-MARCH 2025 51
TABLE 16 CLINICAL TRIAL SUPPLIES MARKET: EXPANSIONS, JANUARY 2021-MARCH 2025 51
TABLE 17 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 53
TABLE 18 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED 54
TABLE 19 THERMO FISHER SCIENTIFIC INC.: SERVICE LAUNCHES,
JANUARY 2021-MARCH 2025 55
TABLE 20 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-MARCH 2025 55
TABLE 21 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-MARCH 2025 56
TABLE 22 NOVO HOLDINGS A/S: COMPANY OVERVIEW 57
TABLE 23 NOVO HOLDINGS A/S: SERVICES OFFERED 58
TABLE 24 NOVO HOLDINGS A/S: DEALS, JANUARY 2021-MARCH 2025 59
TABLE 25 NOVO HOLDINGS A/S: EXPANSIONS, JANUARY 2021-MARCH 2025 60
TABLE 26 UNITED PARCEL SERVICE OF AMERICA, INC.: COMPANY OVERVIEW 61
TABLE 27 UNITED PARCEL SERVICE OF AMERICA, INC.: SERVICES OFFERED 61
TABLE 28 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 64
TABLE 29 EUROFINS SCIENTIFIC: SERVICES OFFERED 65
TABLE 30 PIRAMAL PHARMA LIMITED: COMPANY OVERVIEW 67
TABLE 31 PIRAMAL PHARMA LIMITED: SERVICES OFFERED 68
TABLE 32 IQVIA: COMPANY OVERVIEW 70
TABLE 33 IQVIA: SERVICES OFFERED 72
TABLE 34 ICON PLC: COMPANY OVERVIEW 73
TABLE 35 ICON PLC: SERVICES OFFERED 74
TABLE 36 ICON PLC: DEALS, JANUARY 2021-MARCH 2025 75
TABLE 37 LONZA: COMPANY OVERVIEW 76
TABLE 38 LONZA: SERVICES OFFERED 77
TABLE 39 LONZA: DEALS, JANUARY 2021-MARCH 2025 77
TABLE 40 UNIPHAR GROUP PLC: COMPANY OVERVIEW 78
TABLE 41 UNIPHAR GROUP PLC: SERVICES OFFERED 79
TABLE 42 ALMAC GROUP: COMPANY OVERVIEW 80
TABLE 43 ALMAC GROUP: SERVICES OFFERED 80
TABLE 44 ALMAC GROUP: EXPANSIONS, JANUARY 2021-MARCH 2025 81
TABLE 45 SHARP SERVICES, LLC: COMPANY OVERVIEW 82
TABLE 46 SHARP SERVICES, LLC: SERVICES OFFERED 82
TABLE 47 PCI PHARMA SERVICES: COMPANY OVERVIEW 84
TABLE 48 PCI PHARMA SERVICES: SERVICES OFFERED 84
TABLE 49 PCI PHARMA SERVICES: EXPANSIONS, JANUARY 2021-MARCH 2025 85
TABLE 50 PAREXEL INTERNATIONAL (MA) CORPORATION: COMPANY OVERVIEW 86
TABLE 51 PAREXEL INTERNATIONAL (MA) CORPORATION.: SERVICES OFFERED 86
TABLE 52 PAREXEL INTERNATIONAL (MA) CORPORATION:
DEALS, JANUARY 2021-MARCH 2025 87
TABLE 53 BIOCAIR: COMPANY OVERVIEW 88
TABLE 54 BIOCAIR: SERVICES OFFERED 88
TABLE 55 CENCORA, INC.: COMPANY OVERVIEW 89
TABLE 56 CLINIGEN LIMITED: COMPANY OVERVIEW 90
TABLE 57 KLIFO: COMPANY OVERVIEW 91
TABLE 58 IPS PHARMA: COMPANY OVERVIEW 92
TABLE 59 COREX LOGISTICS LIMITED: COMPANY OVERVIEW 93
TABLE 60 OCT GROUP LLC: COMPANY OVERVIEW 94
TABLE 61 MYONEX: COMPANY OVERVIEW 95
TABLE 62 INCEPTUA GROUP: COMPANY OVERVIEW 96
TABLE 63 ANCILLARE, LP: COMPANY OVERVIEW 97
TABLE 64 ADALLEN PHARMA: COMPANY OVERVIEW 98
TABLE 65 CLINICAL SERVICES INTERNATIONAL (CSI): COMPANY OVERVIEW 99
TABLE 66 NUVISAN GMBH: COMPANY OVERVIEW 100
TABLE 67 AENOVA HOLDING GMBH: COMPANY OVERVIEW 101
TABLE 68 CLINICAL TRIAL SUPPLIES MARKET: RISK ASSESSMENT ANALYSIS 105
FIGURE 1 CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 12
FIGURE 2 CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2025 VS. 2030 (USD MILLION) 13
FIGURE 3 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2025 VS. 2030 (USD MILLION) 14
FIGURE 4 CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2025 VS. 2030 (USD MILLION) 14
FIGURE 5 CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 15
FIGURE 6 GEOGRAPHIC SNAPSHOT OF CLINICAL TRIAL SUPPLIES MARKET, 2025?2030 16
FIGURE 7 CLINICAL TRIAL SUPPLIES MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 18
FIGURE 8 NUMBER OF CLINICAL TRIALS PER YEAR, 2004-2024 19
FIGURE 9 CLINICAL TRIAL SUPPLIES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 22
FIGURE 10 CLINICAL TRIAL SUPPLIES MARKET: VALUE CHAIN ANALYSIS 23
FIGURE 11 CLINICAL TRIAL SUPPLIES MARKET: ECOSYSTEM ANALYSIS 25
FIGURE 12 CLINICAL TRIAL SUPPLIES MARKET: PORTER'S FIVE FORCES ANALYSIS 31
FIGURE 13 IMPACT OF AI ON CLINICAL TRIAL SUPPLIES ECOSYSTEM 33
FIGURE 14 REVENUE ANALYSIS OF KEY PLAYERS IN CLINICAL TRIAL SUPPLIES MARKET, 2020-2024 (USD MILLION) 37
FIGURE 15 MARKET SHARE ANALYSIS OF KEY PLAYERS IN
CLINICAL TRIAL SUPPLIES MARKET (2024) 38
FIGURE 16 CLINICAL TRIAL SUPPLIES MARKET:
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 41
FIGURE 17 CLINICAL TRIAL SUPPLIES MARKET: COMPANY FOOTPRINT 42
FIGURE 18 CLINICAL TRIAL SUPPLIES MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 46
FIGURE 19 EV/EBITDA OF KEY VENDORS 49
FIGURE 20 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND
5-YEAR STOCK BETA OF KEY VENDORS 49
FIGURE 21 CLINICAL TRIAL SUPPLIES MARKET: BRAND/SERVICE COMPARATIVE ANALYSIS 50
FIGURE 22 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 54
FIGURE 23 NOVO HOLDINGS A/S: COMPANY SNAPSHOT 58
FIGURE 24 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT 65
FIGURE 25 PIRAMAL PHARMA LIMITED: COMPANY SNAPSHOT 68
FIGURE 26 IQVIA: COMPANY SNAPSHOT 71
FIGURE 27 ICON PLC: COMPANY SNAPSHOT 73
FIGURE 28 LONZA: COMPANY SNAPSHOT 76
FIGURE 29 UNIPHAR GROUP PLC: COMPANY SNAPSHOT 78
FIGURE 30 CLINICAL TRIAL SUPPLIES MARKET: RESEARCH DESIGN 102
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security